For university 'research services' such as biorepositories and gene sequencing and proteomics cores seeking long-term sustainability, a logical thought is whether those efforts might 'exit' the university as stand-alone entities. Do you understand what would be required to migrate a research service line into a viable business? Argo Pond can provide essential help in reframing your service as a viable marketplace business model.
Argo Pond has expertise in the evaluation of early stage life science technologies, particularly 'platform' technologies that provide utility in R&D applications or new diagnostics. We can help establish a technology's value proposition and identify and characterize first users. Better understanding of these fundamentals allow you and your team to better focus their strategy and provide much-needed assurance to potential early investors.